
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.03 | 1.03 | 0.00 |
Shares | 98.97 | 98.97 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.39 | 24.33 |
Price to Book | 7.32 | 4.69 |
Price to Sales | 5.04 | 3.64 |
Price to Cash Flow | 18.08 | 16.28 |
Dividend Yield | 1.64 | 1.27 |
5 Years Earnings Growth | 9.65 | 10.78 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 27.31 | 13.56 |
Consumer Defensive | 21.91 | 5.85 |
Technology | 21.34 | 29.03 |
Communication Services | 12.16 | 9.32 |
Consumer Cyclical | 8.90 | 12.08 |
Financial Services | 5.11 | 14.84 |
Industrials | 3.27 | 12.72 |
Number of long holdings: 29
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Meta Platforms | US30303M1027 | 8.16 | 738.70 | -1.65% | |
Microsoft | US5949181045 | 7.36 | 506.69 | -0.58% | |
Stryker | US8636671013 | 6.58 | 391.41 | +0.45% | |
Philip Morris | US7181721090 | 6.22 | 167.15 | +0.83% | |
Novo Nordisk B | DK0062498333 | 5.44 | 358.8 | 0.00% | |
Visa A | US92826C8394 | 5.02 | 351.97 | +0.60% | |
L'Oreal | FR0000120321 | 4.86 | 397.90 | -1.11% | |
ADP | US0530151036 | 4.85 | 304.05 | -0.02% | |
Waters | US9418481035 | 4.63 | 301.80 | +1.39% | |
IDEXX Labs | US45168D1046 | 3.97 | 647.09 | +0.01% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity I Acc | 11.48B | 1.00 | 6.56 | 12.95 | ||
Fundsmith Equity I Inc | 3.38B | 0.82 | 6.56 | 12.95 | ||
Fundsmith Equity R Inc | 5.14M | 0.64 | 5.91 | 12.27 | ||
Fundsmith Equity T Acc | 3.54B | 0.94 | 6.45 | 12.84 | ||
Fundsmith Equity T Inc | 212.24M | 0.83 | 6.45 | 12.84 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review